The UK Biobank is preparing to release the most comprehensive set of genetic sequencing data ever to assist in developing drugs for various ailments. The £200 million project was a collaboration between the government, Wellcome Trust, Britain’s largest biomedical charity, and four pharmaceutical companies. With data collected from over 500,000 individuals over 15 years, Biobank is a world-leading resource to study the impact of genetics, lifestyle, and ageing on health. The Biobank’s principal investigator, Sir Rory Collins, believes that the data will be a valuable resource for approved scientists conducting health research and could lead to transformative results in the diagnosis, treatment, and cure of diseases around the world.
£ - This article requires a subscription.
A version of this article is available without subscription in The Guardian.
What is this page?
You are reading a summary article on the Privacy Newsfeed, a free resource for DPOs and other professionals with privacy or data protection responsibilities helping them stay informed of industry news all in one place. The information here is a brief snippet relating to a single piece of original content or several articles about a common topic or thread. The main contributor is listed in the top left-hand corner, just beneath the article title.
The Privacy Newsfeed monitors over 300 global publications, of which more than 4,350 summary articles have been posted to the online archive dating back to the beginning of 2020. A weekly roundup is available by email every Friday.